References of "Lancellotti, Patrizio"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailRecommandations européennes sur la prise en charge de l’endocardite infectieuse (partim 1)
IOVINO, Alessandra ULg; MARCHETTA, Stella ULg; DULGHERU, Raluca Elena ULg et al

in Revue Médicale de Liège (2016), 71(6), 281-286

Detailed reference viewed: 11 (1 ULg)
Full Text
Peer Reviewed
See detailPulmonary pressures and outcome in primary mitral regurgitation. Paradigm shift from Rung to Ladder
LANCELLOTTI, Patrizio ULg; MARTINEZ, Christophe ULg; bernard, a

in Journal of the American College of Cardiology (2016), 67(25), 2962-2964

Detailed reference viewed: 14 (0 ULg)
Full Text
Peer Reviewed
See detail2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D. et al

in European Heart Journal (2016)

Detailed reference viewed: 21 (3 ULg)
Full Text
Peer Reviewed
See detail2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D. et al

in European Journal of Heart Failure (2016)

Detailed reference viewed: 21 (2 ULg)
Full Text
Peer Reviewed
See detail2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, Massimo F.; Hoes, Arno W.; Agewall, Stefan et al

in European Heart Journal (2016)

Detailed reference viewed: 30 (2 ULg)
Full Text
Peer Reviewed
See detailA Comparison of 2 Mitral Annuloplasty Rings for Severe Ischemic Mitral Regurgitation: Clinical and Echocardiographic Outcomes.
Fattouch, Khalil; Moscarelli, Marco; Castrovinci, Sebastiano et al

in Seminars in Thoracic and Cardiovascular Surgery (2016), 28(2), 261-268

Controversies regarding the choice of annuloplasty rings for treatment of ischemic mitral regurgitation still exist. Aim of the study is to compare early performance of 2 different rings in terms of rest ... [more ▼]

Controversies regarding the choice of annuloplasty rings for treatment of ischemic mitral regurgitation still exist. Aim of the study is to compare early performance of 2 different rings in terms of rest and exercise echocardiographic parameters (transmitral gradient, systolic pulmonary artery pressure, and mitral valve area), clinical outcomes, and recurrence of mitral regurgitation. From January 2008 till December 2013, prospectively collected data of patients who underwent coronary artery bypass grafting and undersizing mitral valve annuloplasty for severe chronic ischemic mitral regurgitation at our Institution were reviewed. A total of 93 patients were identified; among them 44 had semirigid Memo 3D ring implanted (group A) whereas 49 had a rigid profile 3D ring (group B). At 6 months, recurrent ischemic mitral regurgitation, equal or more than moderate, was observed in 4 and 6 patients in the group A and B, respectively (P = 0.74). Group A showed certain improved valve geometric parameters such as posterior leaflet angle, tenting area, and coaptation depth. Transmitral gradient was significantly higher at rest in the group B (P < 0.0001). During exercise, significant increase of transmitral gradient and systolic pulmonary artery pressure was observed in group B (P < 0.0001). Mitral valve area was not statistically significantly smaller at rest in between groups (P = 0.09); however, it significantly decreased with exercise in group B (P = 0.01). At midterm follow-up, patients in group B were more symptomatic. In patients with chronic ischemic mitral regurgitation, use of semirigid Memo 3D ring when compared to the rigid Profile 3D may be associated with early improved mitral valve geometrical conformation and hemodynamic profile, particularly during exercise. No difference was observed between both groups in recurrent mitral regurgitation. [less ▲]

Detailed reference viewed: 29 (2 ULg)
Peer Reviewed
See detailCARDIAC ONCOLOGY
GALDERISI, Maurizio; PLANA, JC; EDVARDSEN, Thor et al

in THE EACVI TEXTBOOK OF ECHOCARDIOGRAPHY - SECOND EDITION (2016)

Detailed reference viewed: 15 (1 ULg)
Peer Reviewed
See detailHeart valve disease (mitral valve disease): mitral regurgitation
LANCELLOTTI, Patrizio ULg; DULGHERU, Raluca Elena ULg; VANNAN, M. et al

in THE EACVI TEXTBOOK OF ECHOCARDIOGRAPHY - SECOND EDITION (2016)

Detailed reference viewed: 20 (3 ULg)
Peer Reviewed
See detailHeart valve disease: (aorte valve disease): aortic regurgitation
TRIBOUILLOY, C; LANCELLOTTI, Patrizio ULg; PETERS, F. et al

in THE EACVI TEXTBOOK OF ECHOCARDIOGRAPHY - SECOND EDITION (2016)

Detailed reference viewed: 11 (2 ULg)
See detailTHE EACVI ECHOCARDIOGRAPHY TEXTBOOK - SECOND EDITION
LANCELLOTTI, Patrizio ULg; ZAMORANO; HABIB et al

Book published by Oxford University Press (2016)

Detailed reference viewed: 13 (3 ULg)
Peer Reviewed
See detailASSESSMENT OF SECONDARY MITRAL REGURGITATION
DULGHERU, Raluca Elena ULg; INCARNATE, Pierluigui; LANCELLOTTI, Patrizio ULg

in CURRENT APPROACH TO HEART FAILURE (2016)

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailNormal reference values for echocardiography: a call for comparison between ethnicities.
Cosyns, Bernard; LANCELLOTTI, Patrizio ULg

in European Heart Journal - Cardiovascular Imaging (2016), 17(5), 523-4

Detailed reference viewed: 23 (6 ULg)
Full Text
Peer Reviewed
See detailEACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting.
Garbi, Madalina; Edvardsen, Thor; Bax, Jeroen et al

in European heart journal cardiovascular Imaging (2016)

This paper presents the first European appropriateness criteria for the use of cardiovascular imaging in heart failure, derived from voting of the European National Imaging Societies representatives. The ... [more ▼]

This paper presents the first European appropriateness criteria for the use of cardiovascular imaging in heart failure, derived from voting of the European National Imaging Societies representatives. The paper describes the development process and discusses the results. [less ▲]

Detailed reference viewed: 26 (3 ULg)
Full Text
Peer Reviewed
See detailMalignant Mitral Valve Prolapse: Substrates to Ventricular Remodeling and Arrhythmias.
LANCELLOTTI, Patrizio ULg; Garbi, Madalina

in Circulation: Cardiovascular Imaging (2016), 9(8), 005248

Detailed reference viewed: 26 (3 ULg)
Full Text
Peer Reviewed
See detailCalcific aortic stenosis.
Lindman, Brian R.; Clavel, Marie-Annick; Mathieu, Patrick et al

in Nature Reviews. Disease Primers (2016), 2

Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed countries. It is characterized by progressive fibro-calcific remodelling and thickening of the aortic valve leaflets ... [more ▼]

Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed countries. It is characterized by progressive fibro-calcific remodelling and thickening of the aortic valve leaflets that, over years, evolve to cause severe obstruction to cardiac outflow. In developed countries, AS is the third-most frequent cardiovascular disease after coronary artery disease and systemic arterial hypertension, with a prevalence of 0.4% in the general population and 1.7% in the population >65 years old. Congenital abnormality (bicuspid valve) and older age are powerful risk factors for calcific AS. Metabolic syndrome and an elevated plasma level of lipoprotein(a) have also been associated with increased risk of calcific AS. The pathobiology of calcific AS is complex and involves genetic factors, lipoprotein deposition and oxidation, chronic inflammation, osteoblastic transition of cardiac valve interstitial cells and active leaflet calcification. Although no pharmacotherapy has proved to be effective in reducing the progression of AS, promising therapeutic targets include lipoprotein(a), the renin-angiotensin system, receptor activator of NF-kappaB ligand (RANKL; also known as TNFSF11) and ectonucleotidases. Currently, aortic valve replacement (AVR) remains the only effective treatment for severe AS. The diagnosis and staging of AS are based on the assessment of stenosis severity and left ventricular systolic function by Doppler echocardiography, and the presence of symptoms. The introduction of transcatheter AVR in the past decade has been a transformative therapeutic innovation for patients at high or prohibitive risk for surgical valve replacement, and this new technology might extend to lower-risk patients in the near future. [less ▲]

Detailed reference viewed: 34 (3 ULg)
Full Text
Peer Reviewed
See detailCan multiple previous treatment-requiring rejections affect biventricular myocardial function in heart transplant recipients? A two-dimensional speckle-tracking study.
Romano, Giuseppe; Raffa, Giuseppe Maria; Licata, Pamela et al

in International Journal of Cardiology (2016), 209

Detailed reference viewed: 11 (2 ULg)